V94M (p.Val94Met) variant of LEP (Leptin)

V94M (p.Val94Met) in LEP (Leptin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign/likely benign in the context of Monogenic diabetes; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.12 / 1. The record also includes population frequency data, published literature, and structural context.

V94M (p.Val94Met) variant details